Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next?Unlock AI-picked Stocks

U.S. pending home sales drop in November; Omicron poses risk - NAR

Published 12/29/2021, 10:02 AM
Updated 12/29/2021, 10:07 AM
© Reuters. FILE PHOTO: A home with a sign indicating that it is under contract to be sold is seen in a neighborhood of downtown Washington, October 27, 2009. REUTERS/Jim Bourg

(Reuters) - Contracts to buy U.S. previously owned homes fell unexpectedly in November as limited housing stock and lofty prices crimped activity, and the explosion of new coronavirus cases from the fast-spreading Omicron variant poses a risk to the housing market headed into 2022, a trade group said on Wednesday.

The National Association of Realtors (NAR) said its Pending Home Sales Index, based on signed contracts, fell 2.2% last month to 122.4. Pending home sales were lower in all four regions.

Economists polled by Reuters had forecast contracts, which typically become final sales after a month or two, would rise 0.5% in November.

Pending home sales dropped 2.7% in November on a year-on-year basis. Limited inventory has led to double-digit growth in home prices.

"There was less pending home sales action this time around, which I would ascribe to low housing supply, but also to buyers being hesitant about home prices," said Lawrence Yun, NAR's chief economist. "While I expect neither a price reduction, nor another year of record-pace price gains, the market will see more inventory in 2022 and that will help some consumers with affordability."

Demand for housing shot up early in the coronavirus pandemic as Americans decamped from city centers to suburbs and other, less densely populated areas in a hunt for larger homes to accommodate online schooling and working from home.

The market cooled off in the first half of the year as limited inventory lifted prices beyond the reach of many would-be buyers. Also the rollout of vaccines fueled optimism that people would be able to return to work in offices in urban areas and other business districts.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Activity has picked up again in recent months, however. The combined annual sales rate of new and existing U.S. homes reached 7.2 million units in November, the highest since January.

Now, though, new variants of COVID-19 - first Delta and now Omicron - have swept across the country, forcing employers to retreat again on large-scale return-to-office plans. The U.S. coronavirus caseload has shot to a record in the last week, according to a Reuters tally, surpassing the previous peak set early this year.

NAR's Yun said Omicron, the highly transmissible variant seen driving the latest surge in infections, poses a risk to the housing market's performance, as buyers and sellers are sidelined, and home construction is delayed.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.